All News about Clene Inc
Disruptions in Purine Metabolism Cited in Parkinson’s Development
October 02, 2024
Researchers Identify New Gene Behind ALS Onset
July 29, 2024
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Upcoming In-Person FDA Meeting to Discuss CNM-Au8
September 16, 2024
Exposures
Product Safety
Does Multiple Sclerosis Reduce Risk of Developing Dementia?
September 11, 2024
Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
September 06, 2024
Via Benzinga
UCSF Team Tests New Drug That Could Reverse Multiple Sclerosis
August 19, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|